Genertec Universal Medical Group Company Limited (stock code: 02666) has issued its monthly return for the period ended January 31, 2026. The concept of authorized share capital does not apply as the company is incorporated in Hong Kong.

As of the end of January 2026, the company reported 2,014,204,924 issued shares and zero treasury shares, showing no change from the previous month. It also confirmed compliance with the applicable minimum public float requirement.

The existing share option scheme, approved on December 31, 2019, allows for up to 171,630,458 shares to be issued. By January 2026, there were no outstanding nor newly issued shares under this scheme, leaving no adjustments to the total share capital for the period.